IGFLR1 promoter methylation level was not only significantly lower in primary tumor than in normal tissues of kidney (0.891 vs. 0.83, p < 0.001) (Figure 2A), but also revealed a strong correlation with clinical prognosis of ccRCC. This evidence concerns the gene IGFLR1 and nonpapillary renal cell carcinoma.